ID: ALA5276059

Max Phase: Preclinical

Molecular Formula: C39H34ClF3N8O8

Molecular Weight: 835.20

Associated Items:

Representations

Canonical SMILES:  O=C(CNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O)NCCCCNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1

Standard InChI:  InChI=1S/C39H34ClF3N8O8/c40-27-11-8-22(18-26(27)39(41,42)43)49-38(58)48-21-6-9-23(10-7-21)59-24-14-17-44-29(19-24)34(54)46-16-2-1-15-45-32(53)20-47-28-5-3-4-25-33(28)37(57)51(36(25)56)30-12-13-31(52)50-35(30)55/h3-11,14,17-19,30,47H,1-2,12-13,15-16,20H2,(H,45,53)(H,46,54)(H2,48,49,58)(H,50,52,55)

Standard InChI Key:  CJEWOUKSOYWETG-UHFFFAOYSA-N

Associated Targets(Human)

EA.hy 926 (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor beta (5195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 835.20Molecular Weight (Monoisotopic): 834.2140AlogP: 5.33#Rotatable Bonds: 14
Polar Surface Area: 217.03Molecular Species: NEUTRALHBA: 10HBD: 6
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 6#RO5 Violations (Lipinski): 4
CX Acidic pKa: 11.26CX Basic pKa: 4.02CX LogP: 3.78CX LogD: 3.78
Aromatic Rings: 4Heavy Atoms: 59QED Weighted: 0.07Np Likeness Score: -1.17

References

1. Si R, Liu N, Wang J, Zhang Q, Li Y, Pan X, Zhang J..  (2023)  Discovery of selective platelet-derived growth factor receptor-beta (PDGFR-β) bifunctional small-molecule degraders.,  77  [PMID:36508995] [10.1016/j.bmc.2022.117115]

Source